NA-global

ISPOR Asia Pacific Health Policy Update - A Summary Report

Aug 16, 2023

NA-Policy

Korea Health Policy Updates - August 2023

Aug 11, 2023

NA-Policy

The US Drug Price Negotiations

Aug 11, 2023

NA-HQ

The 9th Northern China Annual Pharmacoeconomics Forum

Aug 11, 2023

NA-HEORupdates3

Annual Conference of the Pharmacoeconomics Professional Committee of the Chinese Pharmaceutical Association

Aug 11, 2023

NA-ISPOR

ISPOR Asia Consortium Industry Committee Meeting

Jun 12, 2023

NA-News

South Korea Health Policy Updates – May 2023

May 30, 2023

NA-chapters

Health Care Systems Update in India: The Way Forward

May 23, 2023

NA-HQ

A Health Economist Comments on ChatGPT’s Responses

May 23, 2023

NA-Policy

Pharmacoeconomic Guidelines for Malaysia Second Edition

May 18, 2023

NA-global

Estimating the Return on Investment of Health Technology Assessment India (HTAIn)

May 18, 2023

NA-HQ

Can We Do Better for Health Technology Assessors & Patients? - How to Overcome “Mistrust” in Digital Health Technologies for Asia Pacific

May 17, 2023

NA-Policy

Health Policy Updates from South Korea

Feb 13, 2023

NA-HEORupdates3

A Global View of Risk-Sharing Compensation Mechanisms

Feb 13, 2023

NA-Policy

Japan Update: Discussion Underway for Creating New Drug Pricing Methodology

Feb 13, 2023

NA-chapters

ISPOR Hosts an HTA Roundtable for the Asia Pacific Region

Feb 10, 2023

NA-ISPOR

Value or Volume: Is the APAC Region Transforming into Value-Based Health Care?

Nov 22, 2022

NA-Policy

Health Policy Updates in Asia Pacific – China, Philippines and Singapore

Nov 1, 2022

NA-Policy

Leveraging RWE and Managed Entry Agreements in Asia Pacific

Nov 1, 2022

NA-HQ

Digital Health Innovations: Improving Patient Outcomes and Equity in the Asia Pacific Region

Nov 1, 2022

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×